BioStem Technologies, Inc. (BSEM) Operating cash flow 2024–2025
BioStem Technologies, Inc. (BSEM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$9.9MFY2025 · since FY2024: $24.5M → $9.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.9M | -59.4% |
| FY2024 | $24.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BSEM financial trends
BSEM RevenueBSEM Net incomeBSEM Net marginBSEM Gross profitBSEM Gross marginBSEM Operating incomeBSEM Operating marginBSEM Free cash flowBSEM Capital expendituresBSEM Return on equityBSEM Stock buybacksBSEM Dividends paidBSEM Total assetsBSEM Total liabilitiesBSEM Shareholders’ equityBSEM overview →